Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Merck KGaA patent covers new factor Xa and factor VIIa inhibitors

June 3, 2004

Six months additional exclusivity for Agrylin

June 2, 2004

Argatroban pharmacokinetics studied in hemodialysis patients

May 24, 2004

Novel factor Xa inhibitors covered by BMS patent

May 21, 2004

Novel factor Xa inhibitor with potent anticoagulant and antithrombotic activity

May 19, 2004

Inflazyme discontinues further development of GH-9001

May 18, 2004

TTP-889 successfully completes phase I

May 13, 2004

Exanta completes E.U. mutual recognition procedure

May 12, 2004

Japanese team presents hemoglobin-derived plasmin modulators

May 7, 2004

M-55529: A novel, selective factor Xa inhibitor from Mochida

May 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...